Merck Says S. Korea Should View FTA As Using Strength For Alliances
This article was originally published in PharmAsia News
The South Korea free-trade agreement with the U.S. has prompted concerns in the Asian nation’s pharmaceutical industry, but U.S.-based Merck says it actually offers new opportunities.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.